EN
ページタイトル画像

Urology

Overview

Major interests of Department of Urology are basic and clinical biology of prostate cancer and minimally invasive therapy for genitourinary cancers. Research interests focused on development and testing of new and existing methods for predicting the aggressiveness of prostate cancers. Clinical interests are focused on development of nomograms to help patients and their physicians decide among the major treatment choices for prostate cancers and non-malignant conditions. Surgical interests are focused on development of the new devices assisting laparoscopic and robotic surgeries.

Professor:
Tomohiko Ichikawa, M.D.,Ph.D.

TEL: +81-43-226-2134
FAX: +81-43-226-2136
e-mail: tomohiko_ichikawa●faculty.chiba-u.jp
URL: http://www.m.chiba-u.ac.jp/class/urology/

※　Please change "●" mark to at-mark if you send emails.

25.jpg

Research & Education

  1. Laparoscopic surgery for adrenal tumor, renal and urothelial cancers
  2. Robotic Surgery for renal and urothelial cancers, bladder cancer and prostate cancer
  3. Cause and prevention of urolithiasis
  4. Genetic diagnosis of renal and urothelial cancers
  5. Tumor immunity in advanced renal cancer
  6. Pathogenesis of neurogenic bladder
  7. Tumor-suppressor genes and metastasis-suppressor genes for prostate cancer
  8. Mechanism of development of castration-resistant prostate cancer
  9. New treatment for advanced prostate cancer
  10. Male infertility and sexual dysfunction
25図.jpg

Recent Publications

  • “Functional analysis of LAT3 in prostate cancer: Its downstream target and relationship with androgen receptor.” Rii J, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Yamada Y, Maimaiti M, Ando K, Wakai K, Xu M, Imamura Y, Shindo N, Hirota T, Kaneda A, Kanai Y, Ikehara Y, Anzai N, Ichikawa T. Cancer Sci. 2021 Sep;112(9):3871-3883.
  • “The heavy chain of 4F2 antigen promote prostate cancer progression via SKP-2.” Maimaiti M, Sakamoto S, Sugiura M, Kanesaka M, Fujimoto A, Matsusaka K, Xu M, Ando K, Saito S, Wakai K, Imamura Y, Nakayama K, Kanai Y, Kaneda A, Ikehara Y, Ikeda JI, Anzai N, Ichikawa T. Sci Rep. 2021 Jun 1;11(1):11478.
  • “Identification of AR-V7 downstream genes commonly targeted by AR/AR-V7 and specifically targeted by AR-V7 in castration resistant prostate cancer.” Sugiura M, Sato H, Okabe A, Fukuyo M, Mano Y, Shinohara KI, Rahmutulla B, Higuchi K, Maimaiti M, Kanesaka M, Imamura Y, Furihata T, Sakamoto S, Komiya A, Anzai N, Kanai Y, Luo J, Ichikawa T, Kaneda A. Transl Oncol. 2021 Jan;14(1):100915.